Pre-order Enquiry
Request Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Sodium hyaluronate eye drops are also known as 'artificial tears'. They are used to relieve eye dryness and soreness.
Asia-Pacific has the largest global market share in Sodium Hyaluronate Eye Drops market which account for 46.40%, while the Europe is the second market share of 18.96% for Sodium Hyaluronate Eye Drops in 2018.
Market Analysis and Insights: Global Sodium Hyaluronate Eye Drops Market
The global Sodium Hyaluronate Eye Drops market was valued at US$ 335.1 in 2020 and will reach US$ 478.1 million by the end of 2027, growing at a CAGR of 6.1% during 2022-2027.
Global Sodium Hyaluronate Eye Drops Scope and Market Size
The global Sodium Hyaluronate Eye Drops market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sodium Hyaluronate Eye Drops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
0.001
0.0015
0.003
Others
Segment by Application
Dry Eye
Rewetting
Others
The Sodium Hyaluronate Eye Drops market is analysed and market size information is provided by regions (countries). Segment by Application, the Sodium Hyaluronate Eye Drops market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex
Asia-Pacific has the largest global market share in Sodium Hyaluronate Eye Drops market which account for 46.40%, while the Europe is the second market share of 18.96% for Sodium Hyaluronate Eye Drops in 2018.
Market Analysis and Insights: Global Sodium Hyaluronate Eye Drops Market
The global Sodium Hyaluronate Eye Drops market was valued at US$ 335.1 in 2020 and will reach US$ 478.1 million by the end of 2027, growing at a CAGR of 6.1% during 2022-2027.
Global Sodium Hyaluronate Eye Drops Scope and Market Size
The global Sodium Hyaluronate Eye Drops market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sodium Hyaluronate Eye Drops market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
0.001
0.0015
0.003
Others
Segment by Application
Dry Eye
Rewetting
Others
The Sodium Hyaluronate Eye Drops market is analysed and market size information is provided by regions (countries). Segment by Application, the Sodium Hyaluronate Eye Drops market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
URSAPHARM Arzneimittel GmbH
Santen
Bayer Inc.
Bausch & Lomb
Johnson & Johnson
The United Laboratories
Alcon
Novax Pharma
Rohto
Thea Pharmaceuticals
Scope Ophthalmics Ltd
Prestige Consumer Healthcare
Medicom Healthcare Ltd
Altacor
Optrex
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
